InsidersTradesSigma
Follow the Goldline Pharmaceutical share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €403.4m. The latest transaction was reported on 23 June 2026 (Acquisition). Among the most active insiders: Swapan Khandelwal. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Goldline Pharmaceutical is a company focused on the development and marketing of pharmaceuticals. It operates in the XBOM market.